Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations
| Image |  |
|---|---|
| Description | scientific article published on 12 December 2019 |
| Author/s |
author: Vassiliki Papadimitrakopoulou |
| Publication date | December 12, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |